UB Paderborn / Katalog / Suche / in CDI

Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma

Supportive care in cancer, 2022-03, Vol.30 (3), p.2131-2139

2022

Link zum Volltext

Verfügbarkeit prüfen

Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study

International journal of clinical oncology, 2020-10, Vol.25 (10), p.1757-1762

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors for Survival in Transverse Colon Cancers

Journal of gastrointestinal cancer, 2022-03, Vol.53 (1), p.31-40

2022

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Cancer chemotherapy and pharmacology, 2019-01, Vol.83 (1), p.115-122

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma

Tumori, 2022-04, Vol.108 (2), p.141-146

2022

Link zum Volltext

Verfügbarkeit prüfen

Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer

Cancer chemotherapy and pharmacology, 2019-04, Vol.83 (4), p.735-742

2019

Link zum Volltext

Verfügbarkeit prüfen

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer

Balkan medical journal, 2016-07, Vol.33 (4), p.407-410

2016

Link zum Volltext

Verfügbarkeit prüfen

A small cell carcinoma in the testis associated with testicular teratoma

Balkan medical journal, 2014-06, Vol.31 (2), p.191-192

2014

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study on potential drug interactions: A single center experience

Journal of oncological science, 2018-08, Vol.4 (2), p.80-84

2018

Link zum Volltext

Verfügbarkeit prüfen

Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?

Radiation oncology (London, England), 2011-03, Vol.6 (1), p.28-28, Article 28

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical Features of the Patient with Multiple Primary Tumors: Single Center Experience

İstanbul Kuzey Klinikleri, 2017-01, Vol.4 (1), p.43-51

Gökyer, Ali

2017

Link zum Volltext

Verfügbarkeit prüfen

Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma: Case report

Journal of oncological science, 2016-08, Vol.2 (2-3), p.69-70

2016

Link zum Volltext

Verfügbarkeit prüfen

SP-32 - Overcoming the resistance in HER2(+) metastatic breast cancer

Leukemia research, 2019-10, Vol.85, p.S15-S15

Uzunoğlu, Sernaz

2019

Link zum Volltext

Verfügbarkeit prüfen

Overcoming the resistance in HER2(+) metastatic breast cancer

Leukemia research, 2019-10, Vol.85, p.S15

Uzunoğlu, Sernaz

2019

Link zum Volltext

Verfügbarkeit prüfen

An Unusual Presentation of Merkel Cell Carcinoma

Balkan medical journal, 2012-03, Vol.29 (1), p.112-114

2012

Link zum Volltext

Verfügbarkeit prüfen

Incidence of contrast-induced nephropathy in hospitalised patients with cancer

European radiology, 2014, Vol.24 (1), p.184-190

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17509-e17509

2023

Link zum Volltext

Verfügbarkeit prüfen

Relationship between prognostic nutritional index and neutrophil lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving regorafenib

Journal of cancer research and therapeutics, 2023-07, Vol.19 (3), p.762-767

2023

Link zum Volltext

Verfügbarkeit prüfen

Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma : A retrospective single-center study

Cancer, 2007-09, Vol.110 (5), p.1068-1076

2007

Link zum Volltext

Verfügbarkeit prüfen

The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2021-05, Vol.26 (3), p.1034

2021

Link zum Volltext

Verfügbarkeit prüfen

Performance status is an important prognostic factor in second line treatment of pancreaticobiliary adenocarcinoma

Hepato-gastroenterology, 2013-09, Vol.60 (126), p.1479

2013

Link zum Volltext

Verfügbarkeit prüfen

Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2021-09, Vol.26 (5), p.2196

2021

Link zum Volltext

Verfügbarkeit prüfen

Skeletal muscle loss during anti-epidermal growth factor receptor therapy is an independent prognostic factor on non-small cell lung cancer patients survival

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2021-05, Vol.26 (3), p.853

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2021-07, Vol.26 (4), p.1628

2021

Link zum Volltext

Verfügbarkeit prüfen

Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients

Hepato-gastroenterology, 2015-06, Vol.62 (140), p.876

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma

Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study

Prognostic Factors for Survival in Transverse Colon Cancers

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma

Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer

A small cell carcinoma in the testis associated with testicular teratoma

A retrospective study on potential drug interactions: A single center experience

Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?

Clinical Features of the Patient with Multiple Primary Tumors: Single Center Experience

Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma: Case report

SP-32 - Overcoming the resistance in HER2(+) metastatic breast cancer

Overcoming the resistance in HER2(+) metastatic breast cancer

An Unusual Presentation of Merkel Cell Carcinoma

Incidence of contrast-induced nephropathy in hospitalised patients with cancer

Safety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

Relationship between prognostic nutritional index and neutrophil lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving regorafenib

Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma : A retrospective single-center study

The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment

Performance status is an important prognostic factor in second line treatment of pancreaticobiliary adenocarcinoma

Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?

Skeletal muscle loss during anti-epidermal growth factor receptor therapy is an independent prognostic factor on non-small cell lung cancer patients survival

Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience

Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients

Suchergebnisse filtern